the investor webinar was awesome i thought. Meta xplore seems like a winner lots of work has gone in to this and meta panel and only just released. obviously it will take some time but throw in sonic and other big pathology majors OS and it really underpins the growth in testing for the next five years minimum and the margins on this side of the business are huge. Then therapeutics have many leads going and continuous amounts of opportunities through mining the databank. AI in the medical space.
It got me really excited about the potential of Microba and nice cash balance.
Ann: Q4 FY23 Quarterly Investor Presentation, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MAP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.003(1.54%) |
Mkt cap ! $71.65M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 16.0¢ | $7.544K | 47.15K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 38147 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 6666 | 1 |
View Market Depth
| Last trade - 11.01am 03/07/2024 (20 minute delay) ? |
| MAP (ASX) Chart |